Kanesa-thasan Niranjan's Form 4 filing
Icosavax, Inc. (ICVX) · filed Aug 2, 2022
- Accession no.
- 0001209191-22-044017
- Filed
- Aug 2, 2022
- Trade date
- Jul 29-Aug 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $21.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kanesa-thasan NiranjanCIK 0001874021 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | SSaleDisposed | −701 | $7.11 | −$4,984.11 | 241,858 | Direct | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −2,001 | $6.64 | −$13,286.64 | 239,857 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −543 | $6.70 | −$3,638.1 | 239,314 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.